Sustanon 250

Four Esters, One Hormone#

Sustanon is a prodrug blend — not a unique molecule. Once the oil depot sits in muscle, non-specific plasma and tissue esterases cleave the ester bond on each of the four testosterone derivatives (propionate, phenylpropionate, isocaproate, decanoate), liberating free testosterone that is pharmacodynamically identical to what your own Leydig cells produce. The only thing the four esters change is release kinetics: short chains (prop, phenylprop) unload fast for the 24–48h peak, long chains (isocap, decanoate) trickle out over the next 2–3 weeks to set the floor.

"After intramuscular administration of Sustanon 250, a dose of 250 mg results in cumulative testosterone release for approximately three weeks, with highest testosterone levels achieved in 24 to 48 hours." — Organon / Aspen, Electronic Medicines Compendium (SmPC), 2023

Practical takeaway: the molecule doing work in your body is just testosterone. Everything below applies equally to enanthate, cypionate, or propionate — Sustanon is differentiated by PK, not pharmacology.

Androgen Receptor Activation and Muscle Hypertrophy#

Free testosterone diffuses into myocytes, binds the cytoplasmic androgen receptor (AR), translocates to the nucleus, and drives transcription of hypertrophy-linked genes — IGF-1, mechano-growth factor (MGF), ribosomal machinery — while suppressing myostatin and glucocorticoid-mediated catabolism. The net effect is increased muscle protein synthesis, positive nitrogen balance, and satellite cell activation. This is the core reason a lifter running 500 mg/week outgains a natty on identical training and food.

"We found that supraphysiologic doses of testosterone, administered as testosterone enanthate, increased fat-free mass, muscle size, and strength in normal men." — Bhasin S, Storer TW, Berman N, et al., New England Journal of Medicine, 1996

Testosterone's AR binding affinity is the reference point (anabolic:androgenic = 100:100) — every other AAS is graded against it. The dose-response is logarithmic: most of the lean mass and strength ROI sits between 300–600 mg/week, with diminishing returns above that and disproportionate side-effect load past ~750 mg/week.

5α-Reduction to DHT (Androgenic Tissues)#

In tissues expressing 5α-reductase — scalp, skin, prostate, seminal vesicles — testosterone is converted to dihydrotestosterone (DHT), which binds AR with roughly 3–5× the affinity and dissociates more slowly. DHT is what drives the androgenic side of the ledger:

• Libido, morning wood, aggression, dominance: the good half
• Acne, oily skin, MPB acceleration, BPH, prostate growth: the cost

This is why a hair-conscious user running Sustanon will stack topical finasteride (limits scalp DHT without crushing systemic DHT and libido) or topical RU58841 (direct scalp AR antagonism, no 5-AR involvement). Oral finasteride works but blunts DHT systemically and some users notice a flatter, less "masculine" cycle feel.

Aromatization to Estradiol#

Testosterone is also a substrate for aromatase (CYP19A1) in adipose tissue, liver, and brain, converting a fraction to estradiol (E2). Unlike nandrolone or trenbolone, Sustanon aromatizes freely — E2 will climb roughly in proportion to dose and body fat. E2 is not the enemy; it drives libido, lipid profile, bone density, joint lubrication, and CNS function. Problems come from imbalance:

The community protocol is to dose anastrozole 0.25–0.5 mg E3D reactively based on sensitive E2 bloods — not prophylactically. Fatter users aromatize more; lean users sometimes need no AI at all on 500 mg/week.

HPG Axis Suppression#

Exogenous testosterone shuts down the hypothalamic GnRH pulse → pituitary stops releasing LH and FSH → testicular Leydig cells stop producing endogenous T, and Sertoli cells halt spermatogenesis. Intratesticular testosterone — which is ~100× serum levels and required for sperm production — collapses within 2–4 weeks. This is why testicular atrophy and infertility are predictable, not exceptional, outcomes.

"Prolonged high-dose testosterone ester use predictably suppresses the hypothalamic–pituitary–gonadal axis, resulting in infertility and significant testosterone withdrawal symptoms upon cessation." — Grant B, Hyams E, Davies R, Minhas S, Jayasena CN, Annals of the New York Academy of Sciences, 2024

Running HCG 250–500 IU twice weekly during cycle mimics LH at the testes, preserves testicular volume and intratesticular T, and dramatically smooths PCT. Without HCG, recovery with a proper SERM PCT (Nolvadex 40/40/20/20) still usually works for a first or second cycle — but becomes progressively less reliable with cycle count, dose, and duration.

Erythropoiesis and Cardiovascular Remodeling#

Testosterone directly stimulates erythropoietin (EPO) production and iron-mediated erythroid maturation — hematocrit and hemoglobin climb measurably within weeks. This boosts oxygen-carrying capacity (useful) but past Hct ~54% thickens blood enough to meaningfully increase thrombotic risk. Donating whole blood every 8–12 weeks fixes this cleanly.

Chronically, supraphysiologic AR activation in cardiac tissue promotes left ventricular hypertrophy and adverse lipid shifts (HDL down, LDL up, ApoB up):

"Long-term anabolic steroid users exhibited increased left ventricular mass and impaired diastolic function compared with nonusers, raising concern for use-associated cardiomyopathy." — Baggish AL, Weiner RB, Kanayama G, et al., Circulation, 2017

This is the real long-term risk ledger — not acute side effects, but cumulative cardiovascular load across years of blasts. Bloodwork discipline (lipids, BP, Hct, ApoB, echo every few years for serious users) is what separates a 20-year career from a 40-year-old with an ejection fraction problem.

Common (most users)#

• Estrogenic bloat / puffy face / soft look — rising E2 from aromatization. Don't reach for an AI reflexively; pull bloods at week 4–6 (sensitive E2 assay) and dose anastrozole 0.25–0.5mg E3D only if symptomatic or E2 is frankly high relative to total T. Crushing E2 is worse than leaving it slightly elevated.
• Acne (back, shoulders, chest) and oily skin — DHT-driven. Benzoyl peroxide 2.5–5% wash, salicylic acid, and dialing nutrition tighten this up for most users. Low-dose isotretinoin (10–20mg/day) is the nuclear option for persistent cases.
• Increased libido / spontaneous erections early cycle, then a mid-cycle dip — the dip is almost always E2 drift (either too high or crushed). Fix E2, not the test dose.
• Injection site soreness ("sus PIP") — the propionate and phenylpropionate fractions bite more than pure enanthate. Warm the oil, use 25G 1–1.5", rotate sites (glute / ventrogluteal / vastus / delt), and split the weekly dose into E3D or EOD pins rather than two big ones.
• Night sweats and disrupted sleep — typically an E2 or peak-T issue. Flattening the curve with more frequent smaller pins fixes it in most users.
• Water retention / BP creep of 5–10 mmHg — monitor with a home cuff. Sodium discipline and cardio handle most of it; stubborn cases respond to a telmisartan 40mg/day script.
• Testicular atrophy — expected. Running HCG 250–500 IU twice weekly throughout cycle keeps the testes functional and makes PCT dramatically easier.

Uncommon (dose-dependent or individual)#

• Gynecomastia (itchy nipples → puffy tissue → palpable lump) — catch it early. Itchy/sensitive nipples warrant an E2 panel and raloxifene 60mg/day or nolvadex 20mg/day until resolved. Don't ignore it — established glandular tissue requires surgery.
• Elevated hematocrit / polycythemia — check CBC at week 6. Hct >52% warrants therapeutic phlebotomy or a blood donation; >54% is a hard stop-and-reassess. Hydration and cardio help but don't fix genuine EPO-driven erythrocytosis.
• Hypertension — dose-linked. If resting BP runs >140/90 consistently, back the dose down, add telmisartan, and re-check. Don't white-knuckle through a cycle with uncontrolled BP.
• Lipid derangement (HDL crash, LDL/ApoB rise) — universal on AAS, magnitude scales with dose. Pull a full lipid panel mid-cycle. Citrus bergamot, fish oil, and cardio blunt it; a statin or ezetimibe is reasonable for users running long cruises.
• Accelerated hair loss in genetically predisposed users — if you have an MPB pattern, start topical finasteride + minoxidil before cycle, not during. Topical antiandrogens like RU58841 are the community standard for scalp protection when running high-androgen cycles without systemic 5-AR suppression.
• Mood lability / irritability ("roid rage" is mostly a myth, but aggression does rise) — usually tracks E2 swings and sleep quality more than raw T. Fix sleep and pin frequency before blaming the compound.
• Prostate enlargement / urinary symptoms — uncommon under 40, more relevant on long cruises. PSA at baseline and annually for users over 35.

"Prolonged high-dose testosterone ester use predictably suppresses the hypothalamic–pituitary–gonadal axis, resulting in infertility and significant testosterone withdrawal symptoms upon cessation." — Grant et al., Annals of the New York Academy of Sciences (2024)

Rare but serious#

• Cardiomyopathy / impaired LV function — multi-year, high-dose use is associated with increased LV mass and diastolic dysfunction. Warning signs: declining exercise tolerance, palpitations, unexplained shortness of breath. Get an echo if you're running long-term or stacking heavily.

"Long-term anabolic steroid users exhibited increased left ventricular mass and impaired diastolic function compared with nonusers, raising concern for use-associated cardiomyopathy." — Baggish et al., Circulation (2017)

• Thrombotic events (DVT, PE, stroke, MI) — driven by polycythemia + lipid damage + BP. This is why Hct monitoring isn't optional.
• Severe anaphylaxis from oil vehicle — arachis (peanut) oil base. Hard contraindication in peanut-allergic users, full stop.
• Persistent post-cycle hypogonadism — failure to recover HPG function after PCT, sometimes permanent. Risk scales with cycle length, dose, frequency of use, and age. Structured PCT, HCG during cycle, and not blasting year-round mitigate but do not eliminate it.
• Hepatic adenoma / peliosis hepatis — essentially a concern with 17α-alkylated orals, not injectable T itself. Relevant when Sustanon is stacked with dbol, anadrol, or superdrol.
• "Sus cough" — brief, alarming but self-limiting cough/chest tightness post-injection from trace oil in a vessel. Aspirate before injecting to minimize; genuinely dangerous oil embolism is rare.

Hard contraindications#

• Peanut or soy allergy — the oil vehicle is arachis oil. Do not use.
• Known or suspected prostate carcinoma or breast carcinoma — androgens accelerate these cancers.
• Untreated hypertension, active polycythemia (Hct >54%), or uncontrolled dyslipidemia — fix the baseline first or do not cycle.
• Plans for conception in the next 6–12 months — spermatogenesis takes months to recover and recovery is not guaranteed. Bank sperm beforehand if fertility matters.
• Pregnancy or possibility of pregnancy in a partner handling the vial — androgens are teratogenic to a female fetus. Not a concern for the user; is a concern for household contact.

Women and PCT considerations#

Women: Sustanon is not appropriate for female use at any bodybuilding-relevant dose. Virilization — voice deepening (irreversible), clitoral hypertrophy (irreversible), hirsutism, androgenic alopecia — occurs rapidly at doses that produce physique changes. Women seeking androgenic effects use low-dose oral anavar (5–10mg/day) or primobolan instead, where dose can be titrated and stopped at first sign of virilization.

PCT: mandatory after any Sustanon cycle the user wants to recover from. Because of the decanoate ester, do not start SERMs too early:

Running HCG 250–500 IU twice weekly throughout the cycle is the single highest-leverage move for easing PCT — it keeps the testes responsive and shortens recovery significantly compared to a dry cycle. Expect a functional return to baseline T within 8–16 weeks for a first or second cycle with proper PCT; repeated or long cycles extend this timeline and carry real risk of permanent suppression.